| 000 | 01371 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514030407.0 | ||
| 264 | 0 | _c20020430 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0732-8893 | ||
| 024 | 7 |
_a10.1016/s0732-8893(01)00343-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJones, Ronald N | |
| 245 | 0 | 0 |
_aCiprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)? _h[electronic resource] |
| 260 |
_bDiagnostic microbiology and infectious disease _cMar 2002 |
||
| 300 |
_a213-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
| 650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
| 650 | 0 | 4 |
_aGram-Positive Bacteria _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _abeta-Lactams |
| 700 | 1 | _aPfaller, Michael A | |
| 773 | 0 |
_tDiagnostic microbiology and infectious disease _gvol. 42 _gno. 3 _gp. 213-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0732-8893(01)00343-1 _zAvailable from publisher's website |
| 999 |
_c11834096 _d11834096 |
||